[1]
E. Garlatti Costa, M. Ghersetti, S. Grazioli, and P. Casarin, “Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2”, Ital J Med, vol. 9, no. 1, pp. 82–88, Mar. 2015.